
TY  - JOUR
PY  - 2021//
TI  - How is COVID-19 affecting patients with obsessive-compulsive disorder? A longitudinal study on the initial phase of the pandemic in a Spanish cohort
JO  - European psychiatry
A1  - Alonso, P.
A1  - Bertolín, S.
A1  - Segalàs, J.
A1  - Tubío-Fungueiriño, M.
A1  - Real, E.
A1  - Mar-Barrutia, L.
A1  - Fernández-Prieto, M.
A1  - Carvalho, S.
A1  - Carracedo, A.
A1  - Menchón, J. M.
SP  - e45
EP  - e45
VL  - 64
IS  - 1
N2  - BACKGROUND: Although the consequences of the COVID-19 pandemic on emotional health are evident, little is known about its impact on patients with obsessive-compulsive disorder (OCD).  METHODS: One hundred and twenty-seven patients with OCD who attended a specialist OCD Clinic in Barcelona, Spain, were assessed by phone from April 27 to May 25, 2020, during the early phase of the pandemic, using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and a structured interview that collected clinical and sociodemographic information. <br><br>RESULTS were compared with those for 237 healthy controls from the same geographic area who completed an online survey.  RESULTS: Although 65.3% of the patients with OCD described a worsening of their symptoms, only 31.4% had Y-BOCS scores that increased >25%. The risk of getting infected by SARS-CoV2 was reported as a new obsession by 44.8%, but this only became the main obsessive concern in approximately 10% of the patients. Suicide-related thoughts were more frequent among the OCD cohort than among healthy controls. The presence of prepandemic depression, higher Y-BOCS scores, contamination/washing symptoms, and lower perceived social support all predicted a significantly increased risk of OCD worsening.  CONCLUSIONS: Most patients with OCD appear to be capable of coping with the emotional stress of the COVID-19 outbreak and its consequences during the initial phase of the pandemic. Nevertheless, the current crisis constitutes a risk factor for a significant worsening of symptoms and suicidal ideation. Action is needed to ensure effective and individualized follow-up care for patients with OCD in the COVID-19 era.<p /> <p>Language: en</p>
LA  - en
SN  - 0924-9338
UR  - http://dx.doi.org/10.1192/j.eurpsy.2021.2214
ID  - ref1
ER  -